Key Development California-based biotechnology innovator ALZpath has formalized a comprehensive global licensing agreement with Abbott Laboratories to advance blood-based diagnostic... Read more
Category: Uncategorized
Pharmaceutical Legal Frameworks: Defining Corporate Liability Thresholds via Pfizer’s Generic Antitrust Dismissal
Key Development A U.S. Federal Judge has officially dismissed global biopharmaceutical giant Pfizer from a sweeping multi-state antitrust lawsuit accusing... Read more
Industrial Adhesives Pivot to MedTech: Analyzing H.B. Fuller’s $942 Million Acquisition of Advanced Medical Solutions
Key Development U.S.-based industrial adhesives manufacturer H.B. Fuller has finalized a definitive agreement to acquire Advanced Medical Solutions Group (AMS),... Read more
Externalizing R&D: Big Pharma’s Agile Pipeline Expansion Strategies via Eli Lilly’s Recent Dealmaking
Key Development Global biopharmaceutical leader Eli Lilly has entered into a new strategic research collaboration with Abbisko Therapeutics to drive... Read more
Boardroom Restructuring at Imexpharm: Strategic Transitions Following Livzon’s Mega M&A
Key Development Imexpharm Pharmaceutical Joint Stock Company (Ticker: IMP) has officially announced significant leadership modifications within its Board of Directors... Read more
Globalizing Vietnam’s Pharmaceutical Sector: Strategic Levers from WHO’s NRA Alignment
Key Development Vietnam's National Regulatory Authority (NRA) for medicines and vaccines successfully concluded a comprehensive evaluation by the World Health... Read more
Pharmaceutical Supply Chain Optimization: Strategic Infrastructure Shifts of MNCs in Vietnam
Key Development The Vietnamese pharmaceutical market recently witnessed a significant infrastructure realignment as the Ministry of Health approved the voluntary... Read more
The European Commission approves Gilead’s Trodelvy as a first-line treatment for metastatic triple-negative breast cancer
Biopharmaceutical pioneer Gilead Sciences, Inc. announced that the European Commission (EC) has formally granted marketing authorization for its flagship oncology... Read more
Merck collaborates with Versant Ventures to launch Saturnus Bio to advance precision therapies for rare genetic cardiomyopathies
Global science and technology leader Merck has finalized a strategic research-stage collaboration with premier venture capital firm Versant Ventures to... Read more









